Search Results - "Suminaga, M"

Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent gastric cancer: a Japanese Cooperative Study Group trial (group A) by Taguchi, T, Sakata, Y, Kanamaru, R, Kurihara, M, Suminaga, M, Ota, J, Hirabayashi, N

“…A late phase II clinical study of RP56976 (docetaxel) was conducted in patients with advanced/recurrent gastric cancer as a multicenter cooperative trial…”
Get more information

A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: a cooperative study group trial (group B) by Mai, M, Sakata, Y, Kanamaru, R, Kurihara, M, Suminaga, M, Ota, J, Hirabayashi, N, Taguchi, T, Furue, H

“…A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer was performed to evaluate the anti-tumor activity…”
Get more information

Clinical efficacy of GG032X tablets, a new dosage form of ondansetron (fast dispersing tablet), on cisplatin-induced nausea and emesis by Ariyoshi, Y, Nukariya, N, Akasaka, Y, Suminaga, M, Ota, J, Ikeda, M, Taguchi, T

“…The inhibitory effects of GG032X tablets, a new dosage form (fast dispersing tablet) of ondansetron, 5-HT2 receptor antagonist, on nausea and emesis induced by…”
Get more information

Pharmacokinetic investigation of 5-day multiple dose of tropisetron capsule in patients who had received cisplatin and the usefulness of tropisetron capsule in the treatment of nausea and vomiting by Suminaga, M, Akasaka, Y, Nukariya, N, Kimura, A, Ohtawa, M

“…We have investigated the pharmacokinetics of a 5-day multiple oral dose of 5 mg tropisetron capsule in patients with malignant tumour who had received…”
Get more information

Clinical evaluation of granisetron for nausea and vomiting induced by anticancer drugs--multi-centered placebo-controlled double-blind comparative study by Suminaga, M, Furue, H, Ohta, K, Taguchi, T, Niitani, H, Ogawa, N

“…A placebo-controlled double-blind comparative trial was conducted to objectively assess the antiemetic effect on nausea and vomiting induced by anticancer…”
Get more information

Clinical evaluation of granisetron for nausea and vomiting induced by anticancer drugs--optimal dose-finding study by Suminaga, M, Furue, H, Ohta, K, Taguchi, T, Niitani, H, Ogawa, N

“…The efficacy, safety and usefulness of oral granisetron for nausea and vomiting induced by the administration of anticancer drugs were compared among four…”
Get more information

Clinical phase III study of tropisetron capsule in the treatment of nausea and vomiting induced by anti-cancer drug; a placebo-controlled, multicenter, double-blind comparative study by Kondo, M, Furue, H, Taguchi, T, Niitani, H, Machida, T, Akasaka, Y, Ohta, J, Suminaga, M, Nukariya, N, Kusunoki, T

“…A placebo-controlled, double-blind comparative study of tropisetron capsule was conducted to assess its clinical usefulness for nausea and vomiting induced by…”
Get more information

Clinical phase II study of tropisetron capsule in the treatment of nausea and vomiting induced by anti-cancer drugs by Yakushiji, M, Tanaka, H, Furue, H, Taguchi, T, Niitani, H, Machida, T, Akasaka, Y, Ohta, J, Suminaga, M, Nukariya, N

“…A comparative clinical trial of tropisetron capsule was conducted in three dose groups to investigate its optimal dose on nausea and vomiting induced by…”
Get more information

Clinical phase III study of tropisetron capsule in the treatment of nausea and vomiting induced by carboplatin or non-platinum anti-cancer drugs by Kanamaru, R, Furue, H, Taguchi, T, Niitani, H, Machida, T, Akasaka, Y, Ohta, J, Suminaga, M, Nukariya, N

“…A clinical phase III study of tropisetron capsule was conducted to assess its efficacy, safety and usefulness on nausea and vomiting induced by carboplatin or…”
Get more information

Anti-emetic effect and safety of ondansetron tablet in double-blind comparison with placebo by Ariyoshi, Y, Ota, K, Taguchi, T, Furue, H, Niitani, H, Tsukagoshi, S, Ikeda, M, Akasaka, Y, Ohta, J, Suminaga, M

“…Ondansetron, a selective 5-HT3 receptor antagonist, has already been reported to have a marked effect to alleviate or prevent nausea and vomiting associated…”
Get more information

Examination of inhibitory effect, safety and usefulness of SN-307 (ondansetron) administered orally once daily for 3-5 consecutive days on nausea and emesis associated with non-platinum anti-cancer drugs by Suminaga, M, Furue, H, Taguchi, T, Ota, K, Niitani, H, Tsukagoshi, S, Ariyoshi, Y, Ikeda, M, Akasaka, Y, Ohta, J

“…We examined the anti-emetic effect, safety and usefulness of ondansetron hydrochloride, a selective 5-HT3 receptor antagonist, given orally once daily at the…”
Get more information

Anti-emetic effect and safety of consecutive use of ondansetron injection in cisplatin-induced nausea and emesis by Akasaka, Y, Taguchi, T, Ota, K, Furue, H, Niitani, H, Tsukagoshi, S, Ariyoshi, Y, Ikeda, M, Ohta, J, Suminaga, M

“…Anti-emetic effect, safety and clinical usefulness of Ondansetron injection given in the dose of 4 mg once daily by intravenous administration for 3-5…”
Get more information

Evaluation of SN-307 (ondansetron), given intravenously for the treatment of nausea and vomiting caused by anticancer drugs including cisplatin-open study by Ikeda, M, Taguchi, T, Ota, K, Furue, H, Niitani, H, Tsukagoshi, S, Ariyoshi, Y, Akasaka, Y, Ohta, J, Suminaga, M

“…The anti-emetic effect, safety and clinical usefulness of ondansetron for the treatment of nausea and vomiting caused by anticancer drugs including cisplatin,…”
Get more information

Investigation of anti-emetic effect of ondansetron tablet in multiple doses on nausea and emesis associated with cisplatin by Suminaga, M, Furue, H, Taguchi, T, Niitani, H, Ota, K, Tsukagoshi, S, Ariyoshi, Y, Ikeda, M, Akasaka, Y, Ohta, J

“…The anti-emetic effects, safety and usefulness of ondansetron, a 5-HT3 receptor antagonist, given orally once daily for 3-5 consecutive days, were investigated…”
Get more information

A case of Cushing's syndrome with diabetes, hypertension and ocular hemorrhage followed by secondary adrenal gland hypofunction by Shimada, K, Ishibashi, M, Abe, K, Demura, R, Karibe, M, Sakamoto, K, Suminaga, M, Furue, H, Yamaji, T

Get full text

Study of cardiac function in first stage examination of RA-700. RA-700 Clinical Study Group by Yoshida, F, Asai, R, Majima, H, Tsukagoshi, S, Furue, H, Suminaga, M, Sakamoto, K, Niitani, H, Murata, A, Kurihara, M

“…There are many studies in the literature on the subject of anti-neoplastic drugs for acute and chronic cardiac toxic function. It is important to check…”
Get more information

Interferon-alpha by Furue, H, Mugitani, H, Hirota, F, Suminaga, M

“…Among interferon (IFN)-alpha, beta, gamma, there are no differences in its clinical effects and toxicities. As to IFN-alpha, there are leukocyte IFN,…”
Get more information

Quantitation of proteinuria by the use of protein-to-creatinine ratios in random urine samples by SATO, Masashi, HAIZUKA, Hisatoshi, ASAKURA, Hiroshi, SUMINAGA, Masashi

“…Measurements of protein-to-creatinine ratios (Up/Cr) in simple voided urine samples were compared with 24-hour urinary protein excretions in order to guantify…”
Get full text

Phase I Study of RA-700. RA-700 Clinical Study Group by Majima, H, Tsukagoshi, S, Furue, H, Suminaga, M, Sakamoto, K, Wakabayashi, R, Kishino, S, Niitani, H, Murata, A, Genma, A

“…An antitumor substance, RA-700, isolated from Rubia akane or Rubia cordifolia has the novel structure. Phase I clinical study was conducted by the RA-700…”
Get more information

Evaluation of SN-307 (ondansetron), given intravenously in the treatment of nausea and vomiting caused by anticancer drugs including cisplatin--a placebo-controlled, double-blind comparative study by Ikeda, M, Taguchi, T, Ota, K, Furue, H, Niitani, H, Tsukagoshi, S, Ariyoshi, Y, Akasaka, Y, Ohta, J, Suminaga, M

“…Clinical usefulness of ondansetron as an antiemetic for the treatment of nausea and vomiting induced by anticancer drugs including cisplatin (> or = 50 mg/m2)…”
Get more information